Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A dose reduction versus standard cyclosporine A in steroid-free maintenance immunosuppression after pediatric kidney transplantation
2007-001166-33Phase 4Terminated
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Aug 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cyclosporine and mycophenolate mofetil in kidney transplant immunosuppression (2 arms), sponsored by Universitätsklinikum Erlangen. Primary endpoint: Primary efficacy endpoint. Started Aug 2007; status: terminated.
02
Drugs
cyclosporinemycophenolate mofetil
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2007-001166-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001166-33.